Zobrazeno 1 - 10
of 25
pro vyhledávání: '"EVA SVEHLIKOVA"'
Publikováno v:
Sports, Vol 12, Iss 9, p 232 (2024)
Runner’s high is a euphoric emotional state occurring during and post-physical exercise. Although previous data indicate endocannabinoids’ involvement in animal runner’s high, their role in human runner’s high remains to be established. We in
Externí odkaz:
https://doaj.org/article/df8b77bef1fb48e8b67dd791ada6732c
Autor:
Martina Brunner, Othmar Moser, Reingard Raml, Maximilian Haberlander, Beate Boulgaropoulos, Barbara Obermayer-Pietsch, Eva Svehlikova, Thomas R. Pieber, Harald Sourij
Publikováno v:
Biomolecules, Vol 12, Iss 3, p 466 (2022)
Methods for glucagon analysis suffered in the past from lack of specificity and a narrow sensitivity range, which has led to inaccurate results and to the suggestion that type 1 diabetes (T1D) and type 2 diabetes (T2D) patients have elevated fasting
Externí odkaz:
https://doaj.org/article/cb12d6acbf414baabc6355fc3e9233c7
Autor:
Anna Obermayer, Norbert J. Tripolt, Faisal Aziz, Christoph Högenauer, Felix Aberer, Florian Schreiber, Andreas Eherer, Caren Sourij, Vanessa Stadlbauer, Eva Svehlikova, Martina Brunner, Nandu Goswami, Harald Kojzar, Peter N. Pferschy, Thomas R. Pieber, Harald Sourij
Publikováno v:
Biomolecules, Vol 11, Iss 4, p 574 (2021)
The EndoBarrier™ medical device is a duodenal-jejunal bypass liner designed to mimic the effects of gastric bypass surgery to induce weight loss and glycaemic improvement. In this study, 10 participants with type 2 diabetes mellitus (T2DM), a mean
Externí odkaz:
https://doaj.org/article/cd94d569540d4e4da6a834ac0979fde8
Autor:
Sophie H Narath, Selma I Mautner, Eva Svehlikova, Bernd Schultes, Thomas R Pieber, Frank M Sinner, Edgar Gander, Gunnar Libiseller, Michael G Schimek, Harald Sourij, Christoph Magnes
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161425 (2016)
Bariatric surgery is currently one of the most effective treatments for obesity and leads to significant weight reduction, improved cardiovascular risk factors and overall survival in treated patients. To date, most studies focused on short-term effe
Externí odkaz:
https://doaj.org/article/a86c739739b54c31b1bd0d1d9abd40b1
Autor:
EVA SVEHLIKOVA, KRISTINE NISS ARFELT, ROMAN CAILLETEAU, SIGRID DELLER, KAREN MARGRETE THOMSEN, MARLIES HART, INES MURSIC, THOMAS PIEBER, HANNE HAAHR
Publikováno v:
Diabetes. 71
Insulin icodec is a basal insulin in development for once-weekly (OW) dosing. The aim of this study was to compare the hypoglycemia frequency and response after icodec vs. insulin glargine U100 (IGlar) overdosing. In a randomized, open-label, two-per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc0c2d22ae49563ae0b0958ac0e1992f
https://doi.org/10.2337/db22-216-or
https://doi.org/10.2337/db22-216-or
Autor:
Ines Mursic, Christoph Magnes, Thomas R. Pieber, Leon Zakrzewski, Eva Svehlikova, Bernd Tschapeller, Jan Jezek, Christina Gatschelhofer, Maria Ratzer, Daniela Schwarzenbacher, David Gerring, Michael Wolf, Thomas Augustin, Martina Urschitz, Franz Feichtner, Sarah Howell, Fiona J. Lawrence
Publikováno v:
Diabetes Care
OBJECTIVE To investigate the pharmacokinetic and pharmacodynamic properties and safety of a novel formulation of insulin aspart (AT247) versus two currently marketed insulin aspart formulations (NovoRapid [IAsp] and Fiasp [faster IAsp]). RESEARCH DES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc225ebb0629860175b4a5e7097ddf3
https://doi.org/10.2337/dc20-1017
https://doi.org/10.2337/dc20-1017
Autor:
Inge B. Halberg, Hanne Haahr, Thomas R. Pieber, Martina Brunner, Eva Svehlikova, Karen Margrete Due Thomsen
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate the pharmacokinetic/pharmacodynamic properties of fast‐acting insulin aspart (faster aspart) versus insulin aspart (IAsp) in people with type 2 diabetes (T2D). Materials and methods In a randomized, double‐blind, crossover des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77f387fa7e15ff1273a2664a0df7eaac
http://europepmc.org/articles/PMC6771872
http://europepmc.org/articles/PMC6771872
Autor:
Peter N. Pferschy, Caren Sourij, F. Schreiber, Eva Svehlikova, Anna Obermayer, Harald Sourij, Vanessa Stadlbauer, Martina Brunner, Christoph Högenauer, Faisal Aziz, Nandu Goswami, Harald Kojzar, Felix Aberer, Andreas Eherer, Thomas R. Pieber, Norbert J. Tripolt
Publikováno v:
Biomolecules
Volume 11
Issue 4
Biomolecules, Vol 11, Iss 574, p 574 (2021)
Volume 11
Issue 4
Biomolecules, Vol 11, Iss 574, p 574 (2021)
The EndoBarrier™ medical device is a duodenal-jejunal bypass liner designed to mimic the effects of gastric bypass surgery to induce weight loss and glycaemic improvement. In this study, 10 participants with type 2 diabetes mellitus (T2DM), a mean
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9a35fcd4f53ad370f59c25a5e4c738
http://europepmc.org/articles/PMC8070956
http://europepmc.org/articles/PMC8070956
Autor:
Barbara Gaigg, John F. Stover, Tina Sartorius, Manfred Wargenau, Angelika Kuchinka-Koch, Susann Schwejda-Guettes, Valentin Faerber, Eva Svehlikova, Annalena Neumann, Ines Mursic, Lioba Pauly, Tamara Esterl, Thomas R. Pieber
Publikováno v:
World Journal of Diabetes
BACKGROUND Lactulose is approved for the symptomatic treatment of constipation, a gastrointestinal (GI) complication common in individuals with diabetes. Lactulose products contain carbohydrate impurities (e.g., lactose, fructose, galactose), which o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23ec3a1e58a1d7d6540c2baadd46d01
https://pubmed.ncbi.nlm.nih.gov/34168736
https://pubmed.ncbi.nlm.nih.gov/34168736
Autor:
Bence Nagy, Gabor Kovacs, Adrienn Tornyos, Eva Svehlikova, Vasile Foris, Chandran Nagaraj, Grazyna Kwapiszewska, Thomas R. Pieber, Andrea Olschewski, Horst Olschewski
Publikováno v:
Pulmonary hypertension.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::219ff51831cbd9a7a59fb91aaf1f72a4
https://doi.org/10.1183/13993003.congress-2020.1496
https://doi.org/10.1183/13993003.congress-2020.1496